|
NIBM Update 11-29-2001 (Number 2) |
|
- Cover -
Holiday message. Big month for Biotechs
- Page 2 -
Titan Pharma releases earnings plus milestones & Pivanex
- Page 3 -
Genta in the news
- Page 4 -
Macro Market notes and analysis
- Page 5 -
NIBM Model Portfolio Updates (DNDN, TGEN, GNTA
|
 |
|
- Page 6 -
News Briefs & Analysis
- All gene therapy trials were halted December 2000
- Researchers use gene chips to better ID lung cancer
- Kirin and GZMO sign joint MAbs agreement
- Alliance Pharma moves Imavist forward (toxic reset info,
too)
|
|
|
| NIBM Updates are
available only to subscribers. In each update we analyze current market trends inside and
outside the biotech market sector. We also provide updates on the companies that appear in
our monthly NIBM Newsletter. Click on the box above to become a
subscriber today! |
Subscriber direct access |
|
| |
|
|
 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
